首页> 外文期刊>Tissue engineering, Part C. Methods >In Vitro Endothelialization of Biodegradable Vascular Grafts Via Endothelial Progenitor Cell Seeding and Maturation in a Tubular Perfusion System Bioreactor
【24h】

In Vitro Endothelialization of Biodegradable Vascular Grafts Via Endothelial Progenitor Cell Seeding and Maturation in a Tubular Perfusion System Bioreactor

机译:通过内皮祖细胞播种和在管状灌注系统生物反应器中成熟的可生物降解血管移植物的体外内皮化。

获取原文
获取原文并翻译 | 示例
           

摘要

A critical challenge to the success of biodegradable vascular grafts is the establishment of a healthy endothelium. To establish this monolayer of endothelial cells (ECs), a variety of techniques have been developed, including cell seeding. Vascular grafts may be seeded with relevant cell types and allowed to mature before implantation. Due to the low proliferative ability of adult ECs and issues with donor site morbidity, there has been increasing interest in using endothelial progenitor cells (EPCs) for vascular healing procedures. In this work, we combined the proliferative and differentiation capabilities of a commercial cell line of early EPCs with an established bioreactor system to support thematuration of cell-seeded vascular grafts. All components of the vascular graft and bioreactor setup are commercially available and allow for complete customization of the scaffold and culturing system. This bioreactor setup enables the control of flow through the graft, imparting fluid shear stress on EPCs and affecting cellular proliferation and differentiation. Grafts cultured with EPCs in the bioreactor system demonstrated greatly increased cell populations and neotissue formation compared with grafts seeded and cultured in a static system. Increased expression of markers for mature endothelial tissues were also observed in bioreactor-cultured EPC-seeded grafts. These findings suggest the distinct advantages of a customizable bioreactor setup for the proliferation and maturation of EPCs. Such a strategy may be beneficial for utilizing EPCs in vascular tissue engineering applications.
机译:可生物降解血管移植物成功的关键挑战是建立健康的内皮细胞。为了建立内皮细胞(EC)的单层,已开发了多种技术,包括细胞接种。血管移植物可以播种相关的细胞类型,并在植入前成熟。由于成人EC的低增殖能力和供体部位发病率的问题,人们越来越关注将内皮祖细胞(EPC)用于血管愈合程序。在这项工作中,我们将早期EPC的商业细胞系的增殖和分化能力与已建立的生物反应器系统结合起来,以支持播种血管移植物的成熟。血管移植物和生物反应器的所有组件均可从市场上买到,并可以完全定制支架和培养系统。这种生物反应器的设置可以控制通过移植物的流量,在EPC上施加流体剪切应力,并影响细胞的增殖和分化。与在静态系统中播种和培养的移植物相比,在生物反应器系统中用EPC培养的移植物显示出大大增加的细胞数量和新组织形成。在生物反应器培养的EPC接种的移植物中,还观察到成熟内皮组织的标志物表达增加。这些发现表明可定制的生物反应器设置对于EPC的增殖和成熟具有明显的优势。这样的策略对于在血管组织工程应用中利用EPC可能是有益的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号